- Company
Austria
Estonia
Finland
Germany
- AIXTRON SE
- BRAIN Biotech AG
- Carl Zeiss Meditec AG
- DEUTZ AG
- EDAG Engineering Group AG
- ElringKlinger AG
- ENCAVIS AG
- Energiekontor AG
- Hypoport SE
- JOST Werke SE
- Knaus Tabbert AG
- LEG Immobilien SE
- Media and Games Invest SE
- Mister Spex SE
- Mountain Alliance AG
- Mutares SE
- Nemetschek SE
- Rational AG
- Schaltbau Holding AG
- SFC Energy AG
- SIXT SE
- Talanx AG
- VARTA AG
- voxeljet AG
- WACKER Chemie AG
- ZEAL Network SE
Italy
Poland
- Sector
- Index
- Verticals
- Speaker
- About
- Blog
January 16, 2023
15:49 
Excerpt
Explore BRAIN Biotech AG’s FY-2022 Financial Performance with CFO Michael Schneiders as he delves into the company’s growth, challenges, and future prospects.
Â
Gain a comprehensive understanding of the group’s structure, including its subsidiaries Akibion Genomics and Brain Incubator, and their impact on the financial landscape.
Â
Uncover the financial highlights, such as revenue growth, adjusted EBITDA, and cash flow, while learning about the company’s regional revenue distribution and strategies for navigating general risk factors. Get a glimpse of BRAIN Biotech’s ambitious targets and share ownership structure as it strives to build a solid foundation for long-term success.
Â
As a leader in industrial biotechnology, BRAIN Biotech AG is dedicated to providing bio-based products and solutions for a more sustainable economy and is a proud participant in the United Nations Global Compact.
Chapters
- Brain at a Glance
- Group Structure
- Highlights FY21/22
- Lowlights FY21/22
- Akibion Genomics
- Brain Incubator
- Financial Highlights FY21/22
- Cash & Cash Flow
- Long-Term Revenue Growth Trajectory
- Adjusted Ebitda
- Revenue by Region
- General Risk Factors
- Targets
- Share Ownership
- Financial Calendar
Resources
Host
Share
T&C:
This publication is for informational purposes only and should not be considered investment advice. By using this website, you agree to the terms and conditions outlined in the legal pages at www.seat11a.com/legal/
Continuing the Journey: More Presentations
Discover Additional Elevator Pitches
COMPANIES:
Austria:
Estonia:
Germany:
seat11a – Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESGÂ
Unlock the insights of top publicly listed companies with seat11a.com
Elevate your understanding with powerful Elevator Pitches, Deep-Dive Presentations, and in-depth Financial Analysis
Reviews for BRAIN Biotech AG Financial Results FY 2022 | Exploring Growth, Challenges, and Future Prospects with CFO